Consistently, several translational studies in models of non-small cell lung cancer, renal cell carcinoma or colorectal cancer have shown that anti-VEGF-A, via normalization of vascularization, increases T cell infiltration into the tumors [66–68]. Here, VEGFA is linked to hereditary clear cell renal cell carcinoma.